NCT06932900

Brief Summary

There are several treatment options for patellofemoral instability, but no established guidelines currently exist. An important step toward developing a consensus is to examine the influence of each intervention through the collection of both subjective and objective outcomes. Most outcome measures commonly used for knee pathologies are primarily designed to monitor degenerative conditions (e.g., osteoarthritis) or ligamentous instability (e.g., anterior cruciate ligament rupture). Very few questionnaires are specific to patellar instability, a condition characterized by distinct signs and symptoms compared to other knee disorders. The Banff Patellar Instability Instrument (BPII) was developed with this gap in mind, in accordance with the Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) criteria. This condition-specific tool is designed to subjectively assess the functional impact of patellofemoral instability on patients' quality of life, which is the most important factor in evaluating treatment success. Currently, there is no validated French-language outcome measure specific to patellofemoral instability. To improve patient care, the availability of such a validated tool in French is essential, both for clinical use and for conducting future research. To address this issue, the primary objective of this study is to translate the Banff Patellar Instability Instrument 2.0 (BPII 2.0) into French, following the three-step process described in the IQOLA project and in accordance with the guidelines outlined by the American Academy of Orthopaedic Surgeons (AAOS), and to evaluate its validity in a French-speaking population. Research Question Is the French version of the BPII 2.0 a valid tool to assess function in French-speaking patients diagnosed with patellofemoral instability? Specific Objectives To translate the Banff Patellar Instability Instrument 2.0 into French using a dual forward-backward translation process. To evaluate the psychometric properties of the French version of the BPII 2.0, including its reliability and validity.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 15, 2021

Completed
3.4 years until next milestone

First Submitted

Initial submission to the registry

April 10, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

3.7 years

First QC Date

April 10, 2025

Last Update Submit

April 10, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Questionnaire Banff Patellar Instability 2.0 Index in French

    Questionnaire. (0-100 (0 = Worst, 100 = Best))

    Baseline, 1 week and 6 month post intervention

  • Questionnaire Anterior Knee Pain Scale (Kujala)

    Questionnaire. (0-100 (0 = Worst, 100 = Best))

    Baseline and 6 month post intervention

  • Socio-Demographic

    Age, Sex, Time since symptoms, Scolarship, Nationality

    Baseline

Study Arms (1)

validation

person with patellar instability that will respond to the questionnaires

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients consulting at the CHUS in Sherbrooke or at the Schriners Hospital in Montreal for patellar instability

You may qualify if:

  • patient diagnosed with patellar instability with conservative or surgical treatment
  • fluent in both spoken and written French

You may not qualify if:

  • Patients who are unable to understand and/or respond to the questionnaire
  • Patients with another diagnosis or knee pathology under study (e.g., complex ligament tear of the knee, gonarthrosis)
  • Patients with another diagnosis or lower limb pathology under study with secondary functional impairment (e.g., coxarthrosis)
  • Patients answering fewer than 19 questions (out of 23 questions)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CIUSSS de l'Estrie-CHUS, 3001, 12e Ave Nord

Sherbrooke, Quebec, J1H5N4, Canada

Location

Study Officials

  • François Vézina, Doctor

    Université de Sherbrooke

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
orthopaedic surgeon

Study Record Dates

First Submitted

April 10, 2025

First Posted

April 17, 2025

Study Start

November 15, 2021

Primary Completion

August 1, 2025

Study Completion

August 1, 2025

Last Updated

April 17, 2025

Record last verified: 2025-04

Locations